Jazz Pharmaceuticals (J7Z) Ownership - Who Owns Jazz Pharmaceuticals?
Jazz Pharmaceuticals (J7Z) Ownership Overview
- 3.33% Insiders
- 32.30% Mutual Funds
- 4.46% Other Institutional Investors
- 28.19% ETFs
- 31.72% Public Companies and Individual Investors
The ownership structure of Jazz Pharmaceuticals (DE:J7Z) stock is a mix of institutional, retail, and individual investors. Approximately 64.95% of the company’s stock is owned by Institutional Investors, 3.33% is owned by Insiders, and 31.72% is owned by Public Companies and Individual Investors.
The ownership structure of Jazz Pharmaceuticals (DE:J7Z) stock is a mix of institutional, retail, and individual investors. Approximately 64.95% of the company’s stock is owned by Institutional Investors, 3.33% is owned by Insiders, and 31.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 31, 2026 | Samantha Pearce | $1,625,977 | |
| May 26, 2026 | Rick Winningham | $662,143 | |
| May 26, 2026 | Heather Ann Mcsharry | $482,000 | |
| Mar 08, 2026 | Patricia Carr | $503,646 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Goalvest Advisory Llc | €51,000 | |
| Dec 31, 2025 | Platinum Investment Management | €76,840 | |
| Dec 31, 2025 | Graham Capital Management, L.p. | €206,380 | |
| Dec 31, 2025 | Innealta Capital, Llc | €235,620 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 6,020,468 | Institution | 9.27% | 1,282,558,359 |
| BlackRock, Inc. | 5,968,603 | Institution | 9.19% | 1,271,509,403 |
| Vanguard | 5,505,033 | Institution | 8.48% | 1,172,753,695 |
| Vanguard Index Funds | 4,844,437 | Institution | 7.46% | 1,032,024,947 |
| American Funds Fundamental Investors | 2,100,000 | Institution | 3.24% | 447,369,300 |
| Capitol Series Trust | 1,561,563 | Institution | 2.41% | 332,664,451 |
| Spdr | 1,380,525 | Institution | 2.13% | 294,097,382 |
| Seamus Mulligan | 1,286,254 | Insider | 1.98% | 274,014,548 |
| Fidelity Select Portfolios | 1,085,952 | Institution | 1.67% | 231,343,612 |
| Dfa | 979,113 | Institution | 1.51% | 208,583,380 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,844,437 | Institution | 7.46% | 1,032,024,947 |
| American Funds Fundamental Investors | 2,100,000 | Institution | 3.24% | 447,369,300 |
| Capitol Series Trust | 1,561,563 | Institution | 2.41% | 332,664,451 |
| Fidelity Select Portfolios | 1,085,952 | Institution | 1.67% | 231,343,612 |
| Fidelity Puritan Trust | 855,427 | Institution | 1.32% | 182,234,180 |
| Fidelity Rutland Square Trust Ii | 789,002 | Institution | 1.22% | 168,083,463 |
| Fidelity Concord Street Trust | 748,648 | Institution | 1.15% | 159,486,729 |
| Dfa Investment Dimensions Group Inc | 677,608 | Institution | 1.04% | 144,352,865 |
| Franklin Strategic Series | 596,738 | Institution | 0.92% | 127,124,886 |
| Fidelity Salem Street Trust | 545,798 | Institution | 0.84% | 116,272,985 |
FAQ
Who Owns Jazz Pharmaceuticals (DE:J7Z)?
According to the latest TipRanks data, approximately 64.95% of the company's stock is held by institutional investors, 3.33% is held by insiders, and 31.72% is held by public companies and individual investors.
What percentage of Jazz Pharmaceuticals (DE:J7Z) stock is held by institutional investors?
According to the latest TipRanks data, approximately 64.95% of Jazz Pharmaceuticals (DE:J7Z) stock is held by institutional investors: 32.30% by mutual funds, 28.19% by ETFs and 4.46% by other institutional investors.
What percentage of Jazz Pharmaceuticals (DE:J7Z) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.72% of Jazz Pharmaceuticals (DE:J7Z) stock is held by public companies and individual investors.
Who owns the most shares of Jazz Pharmaceuticals (DE:J7Z)?
iShares owns the most shares of Jazz Pharmaceuticals (DE:J7Z).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
